Status:
COMPLETED
The Effects of External Counter Pulsation Therapy on Circulating Endothelial Progenitor Cells
Lead Sponsor:
Sheba Medical Center
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
The objectives of the study are to test the hypothesis that external counter pulsation therapy (ECPT) provides clinical benefit by improving the number and function of endothelial progenitor cells (EP...
Detailed Description
ECPT is a non-invasive approach for increasing blood flow to the heart in patients with myocardial ischemia. ECPT produces beneficial effects in coronary artery disease (CAD) patients. However, the ex...
Eligibility Criteria
Inclusion
- coronary artery disease
- CCS angina class II-IV
Exclusion
- aortic regurgitation
- acute myocardial infarction \<3 months
- systemic hypertension \>180/110 mm
- atrial fibrillation
- deep vein thrombosis
- phlebitis and hemorrhagic diathesis
- pregnancy
- abdominal aortic aneurism
- metastatic tumor
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00272571
Start Date
August 1 2004
End Date
January 1 2006
Last Update
January 31 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neufeld cardiac research institute, Sheba medical center
Tel Litwinsky, Israel